LETTER
Synthesis of Unsymmetrical 1,3-Bis- and Trisphosphorus Ligands
1469
(2) (a) Cristau, H.-J.; Virieux, D.; Mouchet, P.; Fruchier, A. Eur.
J. Org. Chem. 1999, 1561. (b) Antczak, M. I.; Montchamp,
J.-L. Tetrahedron Lett. 2008, 49, 5909. (c) Gouault-
Bironneau, S.; Deprèle, S.; Sutor, A.; Montchamp, J.-P. Org.
Lett. 2005, 7, 5909. (d) Inoue, S.; Okauchi, T.; Minami, T.
Synthesis 2003, 1971.
(3) (a) Lecerclé, D.; Gabillet, S.; Gomis, J.-M.; Taran, F.
Tetrahedron Lett. 2008, 49, 2083. (b) Lecerclé, D.; Taran,
F. Synlett 2007, 12, 1863. (c) Sawicki, M.; Siaugue, J. M.;
Jacopin, C.; Moulin, C.; Bailly, T.; Burgada, R.; Meunier, S.;
Baret, P.; Pierre, J. L.; Taran, F. Chem Eur. J. 2005, 11,
3689.
(4) Lecerclé, D.; Sawicki, M.; Taran, F. Org. Lett. 2006, 8,
4283.
(5) (a) Trost, B. M.; Li, C.-J. J. Am. Chem. Soc. 1994, 116,
3167. (b) Alvarez-Ibarra, C.; Csakÿ, A. C.;
Gomez de la Olivia, C. J. Org. Chem. 2000, 65, 3544.
(c) Lu, X.; Zhang, C.; Xu, Z. Acc. Chem. Res. 2001, 34, 535.
(6) (a) Trost, B. M.; Li, C.-J. J. Am. Chem. Soc. 1994, 116,
10819. (b) Alvarez-Ibarra, C.; Csakÿ, A. C.;
(160 MHz, CDCl3): d = –20.76 ppm. MS (ESI/TOF):
m/z = 203 [M + H]+.
General Procedure for g-P-Addition Reaction
The mixture of compound 1 (1 equiv), phosphorus
pronucleophiles (1.2 equiv), and tributylphosphine (0.2
equiv) in 2-PrOH was irradiated under microwave for 30
min at 150 °C. The solvent was evaporated under vacuum,
and the product was purified by column chromatography on
SiO2 (eluent: acetone).
Compound 2a: white solid, mp 87–90 °C. 1H NMR (400
MHz, CDCl3): d = 3.36 (dd, J = 7.6 Hz, J = 15.2 Hz, 2 H),
6.34–6.46 (m, 1 H), 6.47–6.60 (m, 1 H), 7.33–7.56 (m, 16
H), 7.69–7.75 (m, 4 H) ppm. 13C NMR (100 MHz, CDCl3):
d = 36.61 (d, J = 17 Hz), 37.25 (d, J = 17 Hz), 128.45 (d,
J = 12 Hz), 128.76 (d, J = 12 Hz), 129.44 (d, J = 10 Hz),
130.86 (d, J = 10 Hz), 131.25 (d, J = 10 Hz), 131.76 (d, J = 3
Hz), 131.61, 132.12 (d, J = 2 Hz), 132.19, 132.66, 140.17–
140.30 (m)ppm. 31P NMR (160 MHz, CDCl3): d = 23.38,
23.42, 28.96, 29.00 ppm. MS (ESI/TOF): m/z = 443 [M +
H]+.
Gomez de la Olivia, C. Tetrahedron Lett. 1999, 40, 8465.
(7) Trost, B. M.; Li, C.-J. J. Org. Chem. 1997, 62, 5670.
(8) (a) Lu, X.; Tao, X.; Zhu, J.; Sun, X.; Xu, J. Synthesis 1989,
848. (b) Grushin, V. V. Chem. Rev. 2004, 104, 1629.
(c) Kauffmann, T.; Antfang, E.; Olbrich, J. Tetrahedron Lett.
1984, 25, 1963. (d) Han, L.-B.; Zhao, C.-Q. J. Org. Chem.
2005, 70, 10121. (e) Benn, R. F.; Briggs, J. C.; McAuliffe,
C. A. J. Chem. Soc., Dalton Trans. 1984, 293.
(9) General Procedure for the Preparation of Compounds 1
To a soln of phosphoric chloride (5.5 mmol) in dry THF
propynylmagnesium bromide (10 mL, 5 mmol, 0.5 M in
THF) was added dropwise under Ar at –78 °C. The mixture
was stirred at this temperature for 2 h, diluted with Et2O,
washed with a sat. soln of NH4Cl and brine, dried over
MgSO4, filtered, and concentrated under vacuum. The crude
residue was purified by column chromatography on SiO2
(eluent: EtOAc–cyclohexane = 8:2).
General Procedure for Hydrogenation of Compounds 2
and 3
A mixture of 2 and 3 was hydrogenated using Pd/C (0.03
equiv of 10% Pd/C) catalyst in EtOH at r.t. for 24 h. After
filtration, the residue was washed with EtOH (3×). The
combined organic phases were evaporated to give desired
product.
Compound 4a: white solid, mp 142–144 °C. 1H NMR (400
MHz, CDCl3): d = 1.91–2.02 (m, 2 H), 2.43–2.50 (m, 4 H),
7.35–7.46 (m, 12 H), 7.63–7.66 (m, 8 H) ppm. 13C NMR
(100 MHz, CDCl3): d = 14.85, 29.95 (dd, J = 11, 71 Hz),
128.59 (d, J = 12 Hz), 130.61 (d, J = 9 Hz), 131.68 (d, J =
3 Hz), 132.53 (d, J = 98 Hz) ppm. 31P NMR (160 MHz,
CDCl3): d = 32.52 ppm. MS (ESI/TOF): m/z = 445 [M + H]+.
HRMS: m/z calcd for C27H26O2NaP2: 467.1306; found:
467.1312.
Compound 4b: yellow oil. 1H NMR (400 MHz, CDCl3): d =
1.23 (t, J = 7.2 Hz, 6 H), 1.81–1.95 (m, 4 H), 2.38–2.43 (m,
2 H), 3.98–4.03 (m, 4 H), 7.43–7.51 (m, 6 H), 7.69–7.75 (m,
4 H) ppm. 13C NMR (100 MHz, CDCl3): d = 15.29, 16.33 (d,
6 H), 26.26 (dd, J = 14, 140 Hz), 30.00 (d, J = 84 Hz),
128.62 (d, J = 11 Hz), 130.68 (d, J = 10 Hz), 131.73 (d, J =
2 Hz), 132.61 (d, J = 98 Hz) ppm. 31P NMR (160 MHz,
CDCl3): d = 30.58, 32.01 ppm. MS (ESI/TOF): m/z = 381
[M + H]+. HRMS: m/z calcd for C19H26O4NaP2: 403.1204;
found: 403.1211.
Compound 1a: white solid, mp 89–90 °C. 1H NMR (400
MHz, CDCl3): d = 2.11 (d, J = 3.6 Hz, 3 H), 7.43–7.48 (m, 6
H), 7.79–7.85 (m, 4 H) ppm. 13C NMR (100 MHz, CDCl3):
d = 5.02 (d, J = 3 Hz), 75.33 (d, J = 174 Hz), 105.46 (d,
J = 32 Hz), 128.44 (t, J = 10 Hz), 130.81 (d, J = 12 Hz),
132.01 (d, J = 3 Hz), 133.20 (d, J = 121 Hz) ppm. 31P NMR
(160 MHz, CDCl3): d = 7.76 ppm. MS (ESI/TOF): m/z = 241
[M + H]+.
Compound 1b: white solid, mp 67–68 °C. 1H NMR (400
MHz, CDCl3): d = 1.86 (d, J = 14.4 Hz, 3 H), 2.04 (d, J = 3.6
Hz, 3H), 7.47-7.56 (m, 3H), 7.81-7.87 (m, 2H).13C NMR
(100 MHz, CDCl3): d = 4.77 (d, J = 3 Hz), 20.53 (d, J = 86
Hz), 75.22 (d, J = 167 Hz), 103.2 (d, J = 32 Hz), 128.56 (d,
J = 13 Hz), 129.85 (d, J = 11 Hz), 131.99 (d, J = 3 Hz),
133.54 (d, J = 118 Hz) ppm. 31P NMR (160 MHz, CDCl3) d
= 10.17 ppm. MS (ESI/TOF): m/z = 179 [M + H]+.
Compound 1c: white solid, mp 93–94 °C. 1H NMR (400
MHz, CDCl3): d = 2.12 (d, J = 4 Hz, 3 H), 7.41–7.48 (m, 6
H), 7.89–7.92 (m, 4 H) ppm. 13C NMR (100 MHz, CDCl3):
d = 5.39 (d, J = 3 Hz), 73.25 (d, J = 158 Hz), 106.07 (d,
J = 28 Hz), 128.52 (d, J = 14 Hz), 130.73 (d, J = 12 Hz),
131.66 (d, J = 3 Hz), 133.83 (d, J = 97 Hz) ppm. 31P NMR
(160 MHz, CDCl3): d = 19.69 ppm. MS (ESI/TOF): m/z =
257 [M + H]+.
Compound 4c: yellow oil. 1H NMR (400 MHz, CDCl3): d =
1.18–1.24 (m, 3 H), 1.75–2.08 (m, 4 H), 2.35–2.46 (m, 2H);
3.74–3.80 (m, 1 H), 3.95–4.02 (m, 1 H), 7.39–7.51 (m, 9 H),
7.63–7.72 (m, 6 H) ppm. 13C NMR (100 MHz, CDCl3): d =
14.63, 16.35 (d, J = 6 Hz), 30.15 (dd, J = 14, 100 Hz), 60.51
(d, J = 6 Hz), 128.58 (d, J = 12 Hz), 130.67 (d, J = 9 Hz),
131.50 (d, J = 10 Hz), 131.68 (s, l), 132.22–132.27 (m)ppm.
31P NMR (160 MHz, CDCl3): d = 32.17, 43.68 ppm. MS
(ESI/TOF): m/z = 413 [M + H]+. HRMS: m/z calcd for
C23H26O3NaP2: 435.1255; found: 435.1258.
Compound 4d: white solid, mp 145–148 °C. 1H NMR (400
MHz, CDCl3): d = 1.37 (d, J = 12.0 Hz, 6 H), 1.85–1.94 (m,
4 H), 2,37–4,48 (m, 2 H), 7.40–7.47 (m, 6 H), 7.69 (t, J = 8.8
Hz, 4 H) ppm. 13C NMR (100 MHz, CDCl3): d = 14.85,
16.03 (d, J = 68 Hz), 22.12, 30.24 (dd, J = 12, 71 Hz),
31.77–31.83 (m), 32.43 (d, J = 13 Hz), 128.68 (d, J = 12
Hz), 130.62 (d, J = 9 Hz), 131.84 (d, J = 2 Hz), 132.83 ppm.
31P NMR (160 MHz, CDCl3): d = 32.45, 43.33 ppm. MS
(ESI/TOF): m/z = 321 [M + H]+. HRMS: m/z calcd for
C17H22O2NaP2: 343.0993; found: 343.0995.
Compound 1d: white solid, mp 85–86 °C. 1H NMR (400
MHz, CDCl3): d = 1.88 (d, J = 4.0 Hz, 6 H), 7.31–7.41 (m, 3
H), 7.77 (dd, J = 7.2, 15.6 Hz) ppm. 13C NMR (100 MHz,
CDCl3): d = 4.76 (d, J = 4 Hz), 74.85 (d, J = 102 Hz), 103.42
(d, J = 39 Hz), 128.47 (d, J = 15 Hz), 129.92 (d, J = 12 Hz),
132.35 (d, J = 3 Hz), 132.97 (d, J = 141 Hz) ppm. 31P NMR
Synlett 2009, No. 9, 1466–1470 © Thieme Stuttgart · New York